Diversity of human leukocyte antigen-B27 alleles in Han population of Hunan province, southern China

Tissue Antigens

Volumn 68, Issue 2, 2006, Pages 163-166

  Ma, H J ^a   Hu, F P ^a  

^a Central South University   (China)

Author keywords

Ankylosing spondylitis; HLA B27; Spondyloarthropathies; Subtypes

Indexed keywords

GENOMIC DNA; HLA B27 ANTIGEN;

ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CHINA; CONTROLLED STUDY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SPONDYLOARTHROPATHY; ASIAN; CASE CONTROL STUDY; ETHNIC GROUP; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; ETHNIC GROUPS; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SPONDYLITIS, ANKYLOSING;

EID: 33747203226     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00638.x     Document Type: Article

References (28)

1. Khan MA, Ball EJ. Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol 2002: 16: 675-90.
2. Marsh SGE, Albert ED, Bodmer WF et al. Nomenclature for factors of the HLA system, 2004. Int J Immunogenet 2005: 32: 107-59.
3. IMGT/HLA Sequence Database. http://www.ebi.ac.uk/imgt/hla/allele.html
4. Sims AM, Wordsworth BP, Brown MA. Genetic susceptibility to ankylosing spondylitis. Curr Mol Med 2004: 4: 13-20.
5. Brown MA, Jepson A, Young A, Whittle HC, Greenwood BM, Wordsworth BP. Ankylosing spondylitis in West Africans - evidence for a non-HLA-B27 protective effect. Ann Rheum Dis 1997: 56: 68-70.
6. Lopez-Larrea C, Sujirachato K, Mehra NK et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 1995: 45: 169-76.
7. D'Amato M, Fiorillo MT, Carcassi C et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995: 25: 3199-201.
8. Khan MA. HLA-B27 polymorphism and association with disease. J Rheumatol 2000: 27: 1110-4.
9. Paladini F, Taccari E, Fiorillo MT et al. Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum 2005: 34: 3319-21.
10. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984: 27: 361-8.
11. Dougados M, van der Linden S, Juhlin R et al. The European spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991: 34: 1218-27.
12. Voorter CE, Swelsen WT, van den Berg-Loonen EM. B*27 in molecular diagnostics: impact of new alleles and polymorphism outside exons 2 and 3. Tissue Antigens 2002: 60: 25-35.
13. Zino E, Di Terlizzi S, Carugo C et al. Rapid detection of all HLA-B*27 alleles (B*2701-B*2725) by group-specific polymerase chain reaction. Tissue Antigens 2004: 63: 88-92.
14. Garcia-Fernandez S, Gonzalez S, Mina Blanco A et al. New insights regarding HLA-B27 diversity in the Asian population. Tissue Antigens 2001: 58: 259-62.
15. Gonzalez-Roces S, Alvarez MV, Gonzalez S et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997: 49: 116-23.
16. Chou CT, Chen JM, Hsu CM, Chen SJ. HLA-B27 and its subtypes in 4 Taiwanese Aborigine tribes: a comparison to Han Chinese patients with ankylosing spondylitis. J Rheumatol 2003: 30: 321-5.
17. Chen IH, Yang KL, Lee A, Huang HH, Lin PY, Lee TD. Low frequency of HLA-B*2706 in Taiwanese patients with ankylosing spondylitis. Eur J Immunogenet 2002: 29: 435-8.
18. Ramos M, Lopez de Castro JA. HLA-B27 and the pathogenesis of spondyloarthritis. Tissue Antigens 2002: 60: 191-205.
19. Blanco-Gelaz MA, Lopez-Vazquez A, Garcia-Fernandez S, Martinez-Borra J, Gonzalez S, Lopez-Larrea C. Genetic variability, molecular evolution, and geographic diversity of HLA-B27. Hum Immunol 2001: 62: 1042-50.
20. Mehra NK, Kanga U. Molecular diversity of the HLA-B27 gene and its association with disease. Mod Rheumatol 2001: 11: 275-85.
21. Gonzalez S, Garcia-Fernandez S, Martinez-Borra J et al. High variability of HLA-B27 alleles in ankylosing spondylitis and related spondyloarthropathies in the population of northern Spain. Hum Immunol 2002: 63: 673-6.
22. Dhaliwal JS, Too CL, Lisut M, Lee YY, Murad S. HLA-B27 polymorphism in the Malays. Tissue Antigens 2003: 62: 330-2.
23. Shankarkumar U, Ghosh K, Mohanty D. HLA B27 polymorphism in Western India. Tissue Antigens 2002: 60: 98-101.
24. Ren EC, Koh WH, Sim D, Boey ML, Wee GB, Chan SH. Possible protective role of HLA-B*2706 for ankylosing spondylitis. Tissue Antigens 1997: 49: 67-9.
25. Varnavidou-Nicolaidou A, Karpasitou K, Georgiou D et al. HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B*2707. Hum Immunol 2004: 65: 1451-4.
26. Brown MA, Laval SH, Calin A. Recurrence risk modelling of the genetic susceptibility to AS. Ann Rheum Dis 2000: 59: 883-6.
27. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG. Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis. J Hum Genet 2005: 50: 453-9.
28. Steiner NK, Gans C, Baldassarre L et al. Twenty-five novel HLA-B alleles. Tissue Antigens 2003: 62: 263-6.